Astrazeneca Plc Stock Market Value

AZNCF Stock  USD 133.93  7.87  6.24%   
AstraZeneca PLC's market value is the price at which a share of AstraZeneca PLC trades on a public exchange. It measures the collective expectations of AstraZeneca PLC investors about its performance. AstraZeneca PLC is trading at 133.93 as of the 25th of November 2024. This is a 6.24 percent increase since the beginning of the trading day. The stock's lowest day price was 129.55.
With this module, you can estimate the performance of a buy and hold strategy of AstraZeneca PLC and determine expected loss or profit from investing in AstraZeneca PLC over a given investment horizon. Check out AstraZeneca PLC Correlation, AstraZeneca PLC Volatility and AstraZeneca PLC Alpha and Beta module to complement your research on AstraZeneca PLC.
Symbol

Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

AstraZeneca PLC 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AstraZeneca PLC's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AstraZeneca PLC.
0.00
12/06/2022
No Change 0.00  0.0 
In 1 year 11 months and 22 days
11/25/2024
0.00
If you would invest  0.00  in AstraZeneca PLC on December 6, 2022 and sell it all today you would earn a total of 0.00 from holding AstraZeneca PLC or generate 0.0% return on investment in AstraZeneca PLC over 720 days. AstraZeneca PLC is related to or competes with Roche Holding, Roche Holding, Roche Holding, Grifols SA, Bayer AG, Astellas Pharma, and Astellas Pharma. AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercializatio... More

AstraZeneca PLC Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AstraZeneca PLC's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AstraZeneca PLC upside and downside potential and time the market with a certain degree of confidence.

AstraZeneca PLC Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for AstraZeneca PLC's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AstraZeneca PLC's standard deviation. In reality, there are many statistical measures that can use AstraZeneca PLC historical prices to predict the future AstraZeneca PLC's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of AstraZeneca PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
131.58133.93136.28
Details
Intrinsic
Valuation
LowRealHigh
116.84119.19147.32
Details
Naive
Forecast
LowNextHigh
137.29139.63141.98
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
123.89131.31138.73
Details

AstraZeneca PLC Backtested Returns

AstraZeneca PLC secures Sharpe Ratio (or Efficiency) of -0.15, which signifies that the company had a -0.15% return per unit of risk over the last 3 months. AstraZeneca PLC exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm AstraZeneca PLC's Risk Adjusted Performance of (0.1), standard deviation of 2.37, and Mean Deviation of 1.72 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.5, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning AstraZeneca PLC are expected to decrease at a much lower rate. During the bear market, AstraZeneca PLC is likely to outperform the market. At this point, AstraZeneca PLC has a negative expected return of -0.35%. Please make sure to confirm AstraZeneca PLC's accumulation distribution, and the relationship between the potential upside and day median price , to decide if AstraZeneca PLC performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.31  

Below average predictability

AstraZeneca PLC has below average predictability. Overlapping area represents the amount of predictability between AstraZeneca PLC time series from 6th of December 2022 to 1st of December 2023 and 1st of December 2023 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AstraZeneca PLC price movement. The serial correlation of 0.31 indicates that nearly 31.0% of current AstraZeneca PLC price fluctuation can be explain by its past prices.
Correlation Coefficient0.31
Spearman Rank Test-0.18
Residual Average0.0
Price Variance209.26

AstraZeneca PLC lagged returns against current returns

Autocorrelation, which is AstraZeneca PLC pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting AstraZeneca PLC's pink sheet expected returns. We can calculate the autocorrelation of AstraZeneca PLC returns to help us make a trade decision. For example, suppose you find that AstraZeneca PLC has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

AstraZeneca PLC regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If AstraZeneca PLC pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if AstraZeneca PLC pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in AstraZeneca PLC pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

AstraZeneca PLC Lagged Returns

When evaluating AstraZeneca PLC's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of AstraZeneca PLC pink sheet have on its future price. AstraZeneca PLC autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, AstraZeneca PLC autocorrelation shows the relationship between AstraZeneca PLC pink sheet current value and its past values and can show if there is a momentum factor associated with investing in AstraZeneca PLC.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in AstraZeneca Pink Sheet

AstraZeneca PLC financial ratios help investors to determine whether AstraZeneca Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AstraZeneca with respect to the benefits of owning AstraZeneca PLC security.